• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

COVID-19 Impact on Global Orthopedic Oncology Treatment Market Size, Status and Forecast 2020-2026

report cover
  • 22 June 2020
  • Pharmaceuticals
  • 96 Pages
  • Report Code: 24LS-8658
  • Formate :   
Download FREE Report Sample Download PDF File

COVID 19 Impact Orthopedic Oncology Treatment -MARKET ADVISORY SERVICES

This report focuses on the global Orthopedic Oncology Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Orthopedic Oncology Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Stryker Corporation
Zimmer Biomet Holdings, Inc.
Smith & Nephew plc
DePuy Synthes (Johnson & Johnson)
Medtronic
Accentus Medical
Roche Holding AG
Amgen, Inc.
Novartis AG
GlaxoSmithKline
Sanofi
Pfizer Inc.

Market segment by Type, the product can be split into
Soft Tissue Excisions/Resections
Limb Salvage Surgery
Amputation
Adjuvant Chemotherapy
Reconstructive Surgery
Market segment by Application, split into
Hospitals
Clinic
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Orthopedic Oncology Treatment status, future forecast, growth opportunity, key market and key players.
To present the Orthopedic Oncology Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Orthopedic Oncology Treatment are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Orthopedic Oncology Treatment Revenue
1.4 Market Analysis by Type
1.4.1 Global Orthopedic Oncology Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Soft Tissue Excisions/Resections
1.4.3 Limb Salvage Surgery
1.4.4 Amputation
1.4.5 Adjuvant Chemotherapy
1.4.6 Reconstructive Surgery
1.5 Market by Application
1.5.1 Global Orthopedic Oncology Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinic
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Orthopedic Oncology Treatment Industry Impact
1.6.1 How the Covid-19 is Affecting the Orthopedic Oncology Treatment Industry
1.6.1.1 Orthopedic Oncology Treatment Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Orthopedic Oncology Treatment Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Orthopedic Oncology Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 Global Growth Trends by Regions
2.1 Orthopedic Oncology Treatment Market Perspective (2015-2026)
2.2 Orthopedic Oncology Treatment Growth Trends by Regions
2.2.1 Orthopedic Oncology Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Orthopedic Oncology Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Orthopedic Oncology Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Orthopedic Oncology Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Orthopedic Oncology Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Orthopedic Oncology Treatment Players by Market Size
3.1.1 Global Top Orthopedic Oncology Treatment Players by Revenue (2015-2020)
3.1.2 Global Orthopedic Oncology Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Orthopedic Oncology Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Orthopedic Oncology Treatment Market Concentration Ratio
3.2.1 Global Orthopedic Oncology Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Orthopedic Oncology Treatment Revenue in 2019
3.3 Orthopedic Oncology Treatment Key Players Head office and Area Served
3.4 Key Players Orthopedic Oncology Treatment Product Solution and Service
3.5 Date of Enter into Orthopedic Oncology Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global Orthopedic Oncology Treatment Historic Market Size by Type (2015-2020)
4.2 Global Orthopedic Oncology Treatment Forecasted Market Size by Type (2021-2026)

5 Orthopedic Oncology Treatment Breakdown Data by Application (2015-2026)
5.1 Global Orthopedic Oncology Treatment Market Size by Application (2015-2020)
5.2 Global Orthopedic Oncology Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Orthopedic Oncology Treatment Market Size (2015-2020)
6.2 Orthopedic Oncology Treatment Key Players in North America (2019-2020)
6.3 North America Orthopedic Oncology Treatment Market Size by Type (2015-2020)
6.4 North America Orthopedic Oncology Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Orthopedic Oncology Treatment Market Size (2015-2020)
7.2 Orthopedic Oncology Treatment Key Players in Europe (2019-2020)
7.3 Europe Orthopedic Oncology Treatment Market Size by Type (2015-2020)
7.4 Europe Orthopedic Oncology Treatment Market Size by Application (2015-2020)

8 China
8.1 China Orthopedic Oncology Treatment Market Size (2015-2020)
8.2 Orthopedic Oncology Treatment Key Players in China (2019-2020)
8.3 China Orthopedic Oncology Treatment Market Size by Type (2015-2020)
8.4 China Orthopedic Oncology Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Orthopedic Oncology Treatment Market Size (2015-2020)
9.2 Orthopedic Oncology Treatment Key Players in Japan (2019-2020)
9.3 Japan Orthopedic Oncology Treatment Market Size by Type (2015-2020)
9.4 Japan Orthopedic Oncology Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Orthopedic Oncology Treatment Market Size (2015-2020)
10.2 Orthopedic Oncology Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Orthopedic Oncology Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Orthopedic Oncology Treatment Market Size by Application (2015-2020)

11 India
11.1 India Orthopedic Oncology Treatment Market Size (2015-2020)
11.2 Orthopedic Oncology Treatment Key Players in India (2019-2020)
11.3 India Orthopedic Oncology Treatment Market Size by Type (2015-2020)
11.4 India Orthopedic Oncology Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Orthopedic Oncology Treatment Market Size (2015-2020)
12.2 Orthopedic Oncology Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Orthopedic Oncology Treatment Market Size by Type (2015-2020)
12.4 Central & South America Orthopedic Oncology Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Stryker Corporation
13.1.1 Stryker Corporation Company Details
13.1.2 Stryker Corporation Business Overview and Its Total Revenue
13.1.3 Stryker Corporation Orthopedic Oncology Treatment Introduction
13.1.4 Stryker Corporation Revenue in Orthopedic Oncology Treatment Business (2015-2020))
13.1.5 Stryker Corporation Recent Development
13.2 Zimmer Biomet Holdings, Inc.
13.2.1 Zimmer Biomet Holdings, Inc. Company Details
13.2.2 Zimmer Biomet Holdings, Inc. Business Overview and Its Total Revenue
13.2.3 Zimmer Biomet Holdings, Inc. Orthopedic Oncology Treatment Introduction
13.2.4 Zimmer Biomet Holdings, Inc. Revenue in Orthopedic Oncology Treatment Business (2015-2020)
13.2.5 Zimmer Biomet Holdings, Inc. Recent Development
13.3 Smith & Nephew plc
13.3.1 Smith & Nephew plc Company Details
13.3.2 Smith & Nephew plc Business Overview and Its Total Revenue
13.3.3 Smith & Nephew plc Orthopedic Oncology Treatment Introduction
13.3.4 Smith & Nephew plc Revenue in Orthopedic Oncology Treatment Business (2015-2020)
13.3.5 Smith & Nephew plc Recent Development
13.4 DePuy Synthes (Johnson & Johnson)
13.4.1 DePuy Synthes (Johnson & Johnson) Company Details
13.4.2 DePuy Synthes (Johnson & Johnson) Business Overview and Its Total Revenue
13.4.3 DePuy Synthes (Johnson & Johnson) Orthopedic Oncology Treatment Introduction
13.4.4 DePuy Synthes (Johnson & Johnson) Revenue in Orthopedic Oncology Treatment Business (2015-2020)
13.4.5 DePuy Synthes (Johnson & Johnson) Recent Development
13.5 Medtronic
13.5.1 Medtronic Company Details
13.5.2 Medtronic Business Overview and Its Total Revenue
13.5.3 Medtronic Orthopedic Oncology Treatment Introduction
13.5.4 Medtronic Revenue in Orthopedic Oncology Treatment Business (2015-2020)
13.5.5 Medtronic Recent Development
13.6 Accentus Medical
13.6.1 Accentus Medical Company Details
13.6.2 Accentus Medical Business Overview and Its Total Revenue
13.6.3 Accentus Medical Orthopedic Oncology Treatment Introduction
13.6.4 Accentus Medical Revenue in Orthopedic Oncology Treatment Business (2015-2020)
13.6.5 Accentus Medical Recent Development
13.7 Roche Holding AG
13.7.1 Roche Holding AG Company Details
13.7.2 Roche Holding AG Business Overview and Its Total Revenue
13.7.3 Roche Holding AG Orthopedic Oncology Treatment Introduction
13.7.4 Roche Holding AG Revenue in Orthopedic Oncology Treatment Business (2015-2020)
13.7.5 Roche Holding AG Recent Development
13.8 Amgen, Inc.
13.8.1 Amgen, Inc. Company Details
13.8.2 Amgen, Inc. Business Overview and Its Total Revenue
13.8.3 Amgen, Inc. Orthopedic Oncology Treatment Introduction
13.8.4 Amgen, Inc. Revenue in Orthopedic Oncology Treatment Business (2015-2020)
13.8.5 Amgen, Inc. Recent Development
13.9 Novartis AG
13.9.1 Novartis AG Company Details
13.9.2 Novartis AG Business Overview and Its Total Revenue
13.9.3 Novartis AG Orthopedic Oncology Treatment Introduction
13.9.4 Novartis AG Revenue in Orthopedic Oncology Treatment Business (2015-2020)
13.9.5 Novartis AG Recent Development
13.10 GlaxoSmithKline
13.10.1 GlaxoSmithKline Company Details
13.10.2 GlaxoSmithKline Business Overview and Its Total Revenue
13.10.3 GlaxoSmithKline Orthopedic Oncology Treatment Introduction
13.10.4 GlaxoSmithKline Revenue in Orthopedic Oncology Treatment Business (2015-2020)
13.10.5 GlaxoSmithKline Recent Development
13.11 Sanofi
10.11.1 Sanofi Company Details
10.11.2 Sanofi Business Overview and Its Total Revenue
10.11.3 Sanofi Orthopedic Oncology Treatment Introduction
10.11.4 Sanofi Revenue in Orthopedic Oncology Treatment Business (2015-2020)
10.11.5 Sanofi Recent Development
13.12 Pfizer Inc.
10.12.1 Pfizer Inc. Company Details
10.12.2 Pfizer Inc. Business Overview and Its Total Revenue
10.12.3 Pfizer Inc. Orthopedic Oncology Treatment Introduction
10.12.4 Pfizer Inc. Revenue in Orthopedic Oncology Treatment Business (2015-2020)
10.12.5 Pfizer Inc. Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables

Table 1. Orthopedic Oncology Treatment Key Market Segments

Table 2. Key Players Covered: Ranking by Orthopedic Oncology Treatment Revenue

Table 3. Ranking of Global Top Orthopedic Oncology Treatment Manufacturers by Revenue (US$ Million) in 2019

Table 4. Global Orthopedic Oncology Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

Table 5. Key Players of Soft Tissue Excisions/Resections

Table 6. Key Players of Limb Salvage Surgery

Table 7. Key Players of Amputation

Table 8. Key Players of Adjuvant Chemotherapy

Table 9. Key Players of Reconstructive Surgery

Table 10. COVID-19 Impact Global Market: (Four Orthopedic Oncology Treatment Market Size Forecast Scenarios)

Table 11. Opportunities and Trends for Orthopedic Oncology Treatment Players in the COVID-19 Landscape

Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis

Table 13. Key Regions/Countries Measures against Covid-19 Impact

Table 14. Proposal for Orthopedic Oncology Treatment Players to Combat Covid-19 Impact

Table 15. Global Orthopedic Oncology Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026

Table 16. Global Orthopedic Oncology Treatment Market Size by Regions (US$ Million): 2020 VS 2026

Table 17. Global Orthopedic Oncology Treatment Market Size by Regions (2015-2020) (US$ Million)

Table 18. Global Orthopedic Oncology Treatment Market Share by Regions (2015-2020)

Table 19. Global Orthopedic Oncology Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)

Table 20. Global Orthopedic Oncology Treatment Market Share by Regions (2021-2026)

Table 21. Market Top Trends

Table 22. Key Drivers: Impact Analysis

Table 23. Key Challenges

Table 24. Orthopedic Oncology Treatment Market Growth Strategy

Table 25. Main Points Interviewed from Key Orthopedic Oncology Treatment Players

Table 26. Global Orthopedic Oncology Treatment Revenue by Players (2015-2020) (Million US$)

Table 27. Global Orthopedic Oncology Treatment Market Share by Players (2015-2020)

Table 28. Global Top Orthopedic Oncology Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Orthopedic Oncology Treatment as of 2019)

Table 29. Global Orthopedic Oncology Treatment by Players Market Concentration Ratio (CR5 and HHI)

Table 30. Key Players Headquarters and Area Served

Table 31. Key Players Orthopedic Oncology Treatment Product Solution and Service

Table 32. Date of Enter into Orthopedic Oncology Treatment Market

Table 33. Mergers & Acquisitions, Expansion Plans

Table 34. Global Orthopedic Oncology Treatment Market Size by Type (2015-2020) (Million US$)

Table 35. Global Orthopedic Oncology Treatment Market Size Share by Type (2015-2020)

Table 36. Global Orthopedic Oncology Treatment Revenue Market Share by Type (2021-2026)

Table 37. Global Orthopedic Oncology Treatment Market Size Share by Application (2015-2020)

Table 38. Global Orthopedic Oncology Treatment Market Size by Application (2015-2020) (Million US$)

Table 39. Global Orthopedic Oncology Treatment Market Size Share by Application (2021-2026)

Table 40. North America Key Players Orthopedic Oncology Treatment Revenue (2019-2020) (Million US$)

Table 41. North America Key Players Orthopedic Oncology Treatment Market Share (2019-2020)

Table 42. North America Orthopedic Oncology Treatment Market Size by Type (2015-2020) (Million US$)

Table 43. North America Orthopedic Oncology Treatment Market Share by Type (2015-2020)

Table 44. North America Orthopedic Oncology Treatment Market Size by Application (2015-2020) (Million US$)

Table 45. North America Orthopedic Oncology Treatment Market Share by Application (2015-2020)

Table 46. Europe Key Players Orthopedic Oncology Treatment Revenue (2019-2020) (Million US$)

Table 47. Europe Key Players Orthopedic Oncology Treatment Market Share (2019-2020)

Table 48. Europe Orthopedic Oncology Treatment Market Size by Type (2015-2020) (Million US$)

Table 49. Europe Orthopedic Oncology Treatment Market Share by Type (2015-2020)

Table 50. Europe Orthopedic Oncology Treatment Market Size by Application (2015-2020) (Million US$)

Table 51. Europe Orthopedic Oncology Treatment Market Share by Application (2015-2020)

Table 52. China Key Players Orthopedic Oncology Treatment Revenue (2019-2020) (Million US$)

Table 53. China Key Players Orthopedic Oncology Treatment Market Share (2019-2020)

Table 54. China Orthopedic Oncology Treatment Market Size by Type (2015-2020) (Million US$)

Table 55. China Orthopedic Oncology Treatment Market Share by Type (2015-2020)

Table 56. China Orthopedic Oncology Treatment Market Size by Application (2015-2020) (Million US$)

Table 57. China Orthopedic Oncology Treatment Market Share by Application (2015-2020)

Table 58. Japan Key Players Orthopedic Oncology Treatment Revenue (2019-2020) (Million US$)

Table 59. Japan Key Players Orthopedic Oncology Treatment Market Share (2019-2020)

Table 60. Japan Orthopedic Oncology Treatment Market Size by Type (2015-2020) (Million US$)

Table 61. Japan Orthopedic Oncology Treatment Market Share by Type (2015-2020)

Table 62. Japan Orthopedic Oncology Treatment Market Size by Application (2015-2020) (Million US$)

Table 63. Japan Orthopedic Oncology Treatment Market Share by Application (2015-2020)

Table 64. Southeast Asia Key Players Orthopedic Oncology Treatment Revenue (2019-2020) (Million US$)

Table 65. Southeast Asia Key Players Orthopedic Oncology Treatment Market Share (2019-2020)

Table 66. Southeast Asia Orthopedic Oncology Treatment Market Size by Type (2015-2020) (Million US$)

Table 67. Southeast Asia Orthopedic Oncology Treatment Market Share by Type (2015-2020)

Table 68. Southeast Asia Orthopedic Oncology Treatment Market Size by Application (2015-2020) (Million US$)

Table 69. Southeast Asia Orthopedic Oncology Treatment Market Share by Application (2015-2020)

Table 70. India Key Players Orthopedic Oncology Treatment Revenue (2019-2020) (Million US$)

Table 71. India Key Players Orthopedic Oncology Treatment Market Share (2019-2020)

Table 72. India Orthopedic Oncology Treatment Market Size by Type (2015-2020) (Million US$)

Table 73. India Orthopedic Oncology Treatment Market Share by Type (2015-2020)

Table 74. India Orthopedic Oncology Treatment Market Size by Application (2015-2020) (Million US$)

Table 75. India Orthopedic Oncology Treatment Market Share by Application (2015-2020)

Table 76. Central & South America Key Players Orthopedic Oncology Treatment Revenue (2019-2020) (Million US$)

Table 77. Central & South America Key Players Orthopedic Oncology Treatment Market Share (2019-2020)

Table 78. Central & South America Orthopedic Oncology Treatment Market Size by Type (2015-2020) (Million US$)

Table 79. Central & South America Orthopedic Oncology Treatment Market Share by Type (2015-2020)

Table 80. Central & South America Orthopedic Oncology Treatment Market Size by Application (2015-2020) (Million US$)

Table 81. Central & South America Orthopedic Oncology Treatment Market Share by Application (2015-2020)

Table 82. Stryker Corporation Company Details

Table 83. Stryker Corporation Business Overview

Table 84. Stryker Corporation Product

Table 85. Stryker Corporation Revenue in Orthopedic Oncology Treatment Business (2015-2020) (Million US$)

Table 86. Stryker Corporation Recent Development

Table 87. Zimmer Biomet Holdings, Inc. Company Details

Table 88. Zimmer Biomet Holdings, Inc. Business Overview

Table 89. Zimmer Biomet Holdings, Inc. Product

Table 90. Zimmer Biomet Holdings, Inc. Revenue in Orthopedic Oncology Treatment Business (2015-2020) (Million US$)

Table 91. Zimmer Biomet Holdings, Inc. Recent Development

Table 92. Smith & Nephew plc Company Details

Table 93. Smith & Nephew plc Business Overview

Table 94. Smith & Nephew plc Product

Table 95. Smith & Nephew plc Revenue in Orthopedic Oncology Treatment Business (2015-2020) (Million US$)

Table 96. Smith & Nephew plc Recent Development

Table 97. DePuy Synthes (Johnson & Johnson) Company Details

Table 98. DePuy Synthes (Johnson & Johnson) Business Overview

Table 99. DePuy Synthes (Johnson & Johnson) Product

Table 100. DePuy Synthes (Johnson & Johnson) Revenue in Orthopedic Oncology Treatment Business (2015-2020) (Million US$)

Table 101. DePuy Synthes (Johnson & Johnson) Recent Development

Table 102. Medtronic Company Details

Table 103. Medtronic Business Overview

Table 104. Medtronic Product

Table 105. Medtronic Revenue in Orthopedic Oncology Treatment Business (2015-2020) (Million US$)

Table 106. Medtronic Recent Development

Table 107. Accentus Medical Company Details

Table 108. Accentus Medical Business Overview

Table 109. Accentus Medical Product

Table 110. Accentus Medical Revenue in Orthopedic Oncology Treatment Business (2015-2020) (Million US$)

Table 111. Accentus Medical Recent Development

Table 112. Roche Holding AG Company Details

Table 113. Roche Holding AG Business Overview

Table 114. Roche Holding AG Product

Table 115. Roche Holding AG Revenue in Orthopedic Oncology Treatment Business (2015-2020) (Million US$)

Table 116. Roche Holding AG Recent Development

Table 117. Amgen, Inc. Business Overview

Table 118. Amgen, Inc. Product

Table 119. Amgen, Inc. Company Details

Table 120. Amgen, Inc. Revenue in Orthopedic Oncology Treatment Business (2015-2020) (Million US$)

Table 121. Amgen, Inc. Recent Development

Table 122. Novartis AG Company Details

Table 123. Novartis AG Business Overview

Table 124. Novartis AG Product

Table 125. Novartis AG Revenue in Orthopedic Oncology Treatment Business (2015-2020) (Million US$)

Table 126. Novartis AG Recent Development

Table 127. GlaxoSmithKline Company Details

Table 128. GlaxoSmithKline Business Overview

Table 129. GlaxoSmithKline Product

Table 130. GlaxoSmithKline Revenue in Orthopedic Oncology Treatment Business (2015-2020) (Million US$)

Table 131. GlaxoSmithKline Recent Development

Table 132. Sanofi Company Details

Table 133. Sanofi Business Overview

Table 134. Sanofi Product

Table 135. Sanofi Revenue in Orthopedic Oncology Treatment Business (2015-2020) (Million US$)

Table 136. Sanofi Recent Development

Table 137. Pfizer Inc. Company Details

Table 138. Pfizer Inc. Business Overview

Table 139. Pfizer Inc. Product

Table 140. Pfizer Inc. Revenue in Orthopedic Oncology Treatment Business (2015-2020) (Million US$)

Table 141. Pfizer Inc. Recent Development

Table 142. Research Programs/Design for This Report

Table 143. Key Data Information from Secondary Sources

Table 144. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Orthopedic Oncology Treatment Market Share by Type: 2020 VS 2026

Figure 2. Soft Tissue Excisions/Resections Features

Figure 3. Limb Salvage Surgery Features

Figure 4. Amputation Features

Figure 5. Adjuvant Chemotherapy Features

Figure 6. Reconstructive Surgery Features

Figure 7. Global Orthopedic Oncology Treatment Market Share by Application: 2020 VS 2026

Figure 8. Hospitals Case Studies

Figure 9. Clinic Case Studies

Figure 10. Others Case Studies

Figure 11. Orthopedic Oncology Treatment Report Years Considered

Figure 12. Global Orthopedic Oncology Treatment Market Size YoY Growth 2015-2026 (US$ Million)

Figure 13. Global Orthopedic Oncology Treatment Market Share by Regions: 2020 VS 2026

Figure 14. Global Orthopedic Oncology Treatment Market Share by Regions (2021-2026)

Figure 15. Porter's Five Forces Analysis

Figure 16. Global Orthopedic Oncology Treatment Market Share by Players in 2019

Figure 17. Global Top Orthopedic Oncology Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Orthopedic Oncology Treatment as of 2019

Figure 18. The Top 10 and 5 Players Market Share by Orthopedic Oncology Treatment Revenue in 2019

Figure 19. North America Orthopedic Oncology Treatment Market Size YoY Growth (2015-2020) (Million US$)

Figure 20. Europe Orthopedic Oncology Treatment Market Size YoY Growth (2015-2020) (Million US$)

Figure 21. China Orthopedic Oncology Treatment Market Size YoY Growth (2015-2020) (Million US$)

Figure 22. Japan Orthopedic Oncology Treatment Market Size YoY Growth (2015-2020) (Million US$)

Figure 23. Southeast Asia Orthopedic Oncology Treatment Market Size YoY Growth (2015-2020) (Million US$)

Figure 24. India Orthopedic Oncology Treatment Market Size YoY Growth (2015-2020) (Million US$)

Figure 25. Central & South America Orthopedic Oncology Treatment Market Size YoY Growth (2015-2020) (Million US$)

Figure 26. Stryker Corporation Total Revenue (US$ Million): 2019 Compared with 2018

Figure 27. Stryker Corporation Revenue Growth Rate in Orthopedic Oncology Treatment Business (2015-2020)

Figure 28. Zimmer Biomet Holdings, Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 29. Zimmer Biomet Holdings, Inc. Revenue Growth Rate in Orthopedic Oncology Treatment Business (2015-2020)

Figure 30. Smith & Nephew plc Total Revenue (US$ Million): 2019 Compared with 2018

Figure 31. Smith & Nephew plc Revenue Growth Rate in Orthopedic Oncology Treatment Business (2015-2020)

Figure 32. DePuy Synthes (Johnson & Johnson) Total Revenue (US$ Million): 2019 Compared with 2018

Figure 33. DePuy Synthes (Johnson & Johnson) Revenue Growth Rate in Orthopedic Oncology Treatment Business (2015-2020)

Figure 34. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018

Figure 35. Medtronic Revenue Growth Rate in Orthopedic Oncology Treatment Business (2015-2020)

Figure 36. Accentus Medical Total Revenue (US$ Million): 2019 Compared with 2018

Figure 37. Accentus Medical Revenue Growth Rate in Orthopedic Oncology Treatment Business (2015-2020)

Figure 38. Roche Holding AG Total Revenue (US$ Million): 2019 Compared with 2018

Figure 39. Roche Holding AG Revenue Growth Rate in Orthopedic Oncology Treatment Business (2015-2020)

Figure 40. Amgen, Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 41. Amgen, Inc. Revenue Growth Rate in Orthopedic Oncology Treatment Business (2015-2020)

Figure 42. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018

Figure 43. Novartis AG Revenue Growth Rate in Orthopedic Oncology Treatment Business (2015-2020)

Figure 44. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018

Figure 45. GlaxoSmithKline Revenue Growth Rate in Orthopedic Oncology Treatment Business (2015-2020)

Figure 46. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018

Figure 47. Sanofi Revenue Growth Rate in Orthopedic Oncology Treatment Business (2015-2020)

Figure 48. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 49. Pfizer Inc. Revenue Growth Rate in Orthopedic Oncology Treatment Business (2015-2020)

Figure 50. Bottom-up and Top-down Approaches for This Report

Figure 51. Data Triangulation

Figure 52. Key Executives Interviewed

Stryker Corporation

Zimmer Biomet Holdings, Inc.

Smith & Nephew plc

DePuy Synthes (Johnson & Johnson)

Medtronic

Accentus Medical

Roche Holding AG

Amgen, Inc.

Novartis AG

GlaxoSmithKline

Sanofi

Pfizer Inc.

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3120

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase